Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 03/24

Trade details

Type
Insider sale
Amount
$688,221.6
Shares · price
1,320 sh · $521.38 a share
Held after
46,680 sh
Trade date
26/03/23
Filed
26/03/24
Days to filing
1 days

Sold 2.8% of holdings

Share of holding sold
2.8%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 02/21~04/22

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1.1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $664.2K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $574.9K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $262.3K

    Filed 09/30

Martine A. Rothblatt, Chairman — sold $688.2K of United Therapeutics UTHR · 2.8% of holdings · 10b5-1 plan | Whalegun